The genetic landscape of metaplastic breast cancers and uterine carcinosarcomas
Metaplastic breast carcinoma (MBC) and uterine carcinosarcoma (UCS) are rare aggressive cancers, characterized by an admixture of adenocarcinoma and areas displaying mesenchymal/sarcomatoid differentiation. We sought to define whether MBCs and UCSs harbor similar patterns of genetic alterations, and...
Main Authors: | , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-04-01
|
Series: | Molecular Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1002/1878-0261.12813 |
_version_ | 1831537792583204864 |
---|---|
author | Lea A. Moukarzel Lorenzo Ferrando Arnaud Da Cruz Paula David N. Brown Felipe C. Geyer Fresia Pareja Salvatore Piscuoglio Anastasios D. Papanastasiou Nicola Fusco Caterina Marchiò Nadeem R. Abu‐Rustum Rajmohan Murali Edi Brogi Hannah Y. Wen Larry Norton Robert A. Soslow Anne Vincent‐Salomon Jorge S. Reis‐Filho Britta Weigelt |
author_facet | Lea A. Moukarzel Lorenzo Ferrando Arnaud Da Cruz Paula David N. Brown Felipe C. Geyer Fresia Pareja Salvatore Piscuoglio Anastasios D. Papanastasiou Nicola Fusco Caterina Marchiò Nadeem R. Abu‐Rustum Rajmohan Murali Edi Brogi Hannah Y. Wen Larry Norton Robert A. Soslow Anne Vincent‐Salomon Jorge S. Reis‐Filho Britta Weigelt |
author_sort | Lea A. Moukarzel |
collection | DOAJ |
description | Metaplastic breast carcinoma (MBC) and uterine carcinosarcoma (UCS) are rare aggressive cancers, characterized by an admixture of adenocarcinoma and areas displaying mesenchymal/sarcomatoid differentiation. We sought to define whether MBCs and UCSs harbor similar patterns of genetic alterations, and whether the different histologic components of MBCs and UCSs are clonally related. Whole‐exome sequencing (WES) data from MBCs (n = 35) and UCSs (n = 57, The Cancer Genome Atlas) were reanalyzed to define somatic genetic alterations, altered signaling pathways, mutational signatures, and genomic features of homologous recombination DNA repair deficiency (HRD). In addition, the carcinomatous and sarcomatous components of an additional cohort of MBCs (n = 11) and UCSs (n = 6) were microdissected separately and subjected to WES, and their clonal relatedness was assessed. MBCs and UCSs harbored recurrent genetic alterations affecting TP53, PIK3CA, and PTEN, similar patterns of gene copy number alterations, and an enrichment in alterations affecting the epithelial‐to‐mesenchymal transition (EMT)‐related Wnt and Notch signaling pathways. Differences were observed, however, including a significantly higher prevalence of FAT3 and FAT1 somatic mutations in MBCs compared to UCSs, and conversely, UCSs significantly more frequently harbored somatic mutations affecting FBXW7 and PPP2R1A as well as HER2 amplification than MBCs. Genomic features of HRD and biallelic alterations affecting bona fide HRD‐related genes were found to be more prevalent in MBCs than in UCSs. The distinct histologic components of MBCs and UCSs were clonally related in all cases, with the sarcoma component likely stemming from a minor subclone of the carcinoma component in the samples with interpretable chronology of clonal evolution. Despite the similar histologic features and pathways affected by genetic alterations, UCSs differ from MBCs on the basis of FBXW7 and PPP2R1A mutations, HER2 amplification, and lack of HRD, supporting the notion that these entities are more than mere phenocopies of the same tumor type in different anatomical sites. |
first_indexed | 2024-12-16T23:12:53Z |
format | Article |
id | doaj.art-d43d7492291245088deab363a8092b63 |
institution | Directory Open Access Journal |
issn | 1574-7891 1878-0261 |
language | English |
last_indexed | 2024-12-16T23:12:53Z |
publishDate | 2021-04-01 |
publisher | Wiley |
record_format | Article |
series | Molecular Oncology |
spelling | doaj.art-d43d7492291245088deab363a8092b632022-12-21T22:12:22ZengWileyMolecular Oncology1574-78911878-02612021-04-011541024103910.1002/1878-0261.12813The genetic landscape of metaplastic breast cancers and uterine carcinosarcomasLea A. Moukarzel0Lorenzo Ferrando1Arnaud Da Cruz Paula2David N. Brown3Felipe C. Geyer4Fresia Pareja5Salvatore Piscuoglio6Anastasios D. Papanastasiou7Nicola Fusco8Caterina Marchiò9Nadeem R. Abu‐Rustum10Rajmohan Murali11Edi Brogi12Hannah Y. Wen13Larry Norton14Robert A. Soslow15Anne Vincent‐Salomon16Jorge S. Reis‐Filho17Britta Weigelt18Department of Surgery Memorial Sloan Kettering Cancer Center New York NY USADepartment of Pathology Memorial Sloan Kettering Cancer Center New York NY USADepartment of Surgery Memorial Sloan Kettering Cancer Center New York NY USADepartment of Pathology Memorial Sloan Kettering Cancer Center New York NY USADepartment of Pathology Memorial Sloan Kettering Cancer Center New York NY USADepartment of Pathology Memorial Sloan Kettering Cancer Center New York NY USADepartment of Pathology Memorial Sloan Kettering Cancer Center New York NY USADepartment of Pathology Memorial Sloan Kettering Cancer Center New York NY USADepartment of Pathology Memorial Sloan Kettering Cancer Center New York NY USADepartment of Pathology Memorial Sloan Kettering Cancer Center New York NY USADepartment of Surgery Memorial Sloan Kettering Cancer Center New York NY USADepartment of Pathology Memorial Sloan Kettering Cancer Center New York NY USADepartment of Pathology Memorial Sloan Kettering Cancer Center New York NY USADepartment of Pathology Memorial Sloan Kettering Cancer Center New York NY USADepartment of Medicine Memorial Sloan Kettering Cancer Center New York NY USADepartment of Pathology Memorial Sloan Kettering Cancer Center New York NY USADepartment of Pathology Institut Curie Paris FranceDepartment of Pathology Memorial Sloan Kettering Cancer Center New York NY USADepartment of Pathology Memorial Sloan Kettering Cancer Center New York NY USAMetaplastic breast carcinoma (MBC) and uterine carcinosarcoma (UCS) are rare aggressive cancers, characterized by an admixture of adenocarcinoma and areas displaying mesenchymal/sarcomatoid differentiation. We sought to define whether MBCs and UCSs harbor similar patterns of genetic alterations, and whether the different histologic components of MBCs and UCSs are clonally related. Whole‐exome sequencing (WES) data from MBCs (n = 35) and UCSs (n = 57, The Cancer Genome Atlas) were reanalyzed to define somatic genetic alterations, altered signaling pathways, mutational signatures, and genomic features of homologous recombination DNA repair deficiency (HRD). In addition, the carcinomatous and sarcomatous components of an additional cohort of MBCs (n = 11) and UCSs (n = 6) were microdissected separately and subjected to WES, and their clonal relatedness was assessed. MBCs and UCSs harbored recurrent genetic alterations affecting TP53, PIK3CA, and PTEN, similar patterns of gene copy number alterations, and an enrichment in alterations affecting the epithelial‐to‐mesenchymal transition (EMT)‐related Wnt and Notch signaling pathways. Differences were observed, however, including a significantly higher prevalence of FAT3 and FAT1 somatic mutations in MBCs compared to UCSs, and conversely, UCSs significantly more frequently harbored somatic mutations affecting FBXW7 and PPP2R1A as well as HER2 amplification than MBCs. Genomic features of HRD and biallelic alterations affecting bona fide HRD‐related genes were found to be more prevalent in MBCs than in UCSs. The distinct histologic components of MBCs and UCSs were clonally related in all cases, with the sarcoma component likely stemming from a minor subclone of the carcinoma component in the samples with interpretable chronology of clonal evolution. Despite the similar histologic features and pathways affected by genetic alterations, UCSs differ from MBCs on the basis of FBXW7 and PPP2R1A mutations, HER2 amplification, and lack of HRD, supporting the notion that these entities are more than mere phenocopies of the same tumor type in different anatomical sites.https://doi.org/10.1002/1878-0261.12813breast cancercarcinosarcomahomologous recombination DNA repairmetaplasticuterine cancerwhole‐exome sequencing |
spellingShingle | Lea A. Moukarzel Lorenzo Ferrando Arnaud Da Cruz Paula David N. Brown Felipe C. Geyer Fresia Pareja Salvatore Piscuoglio Anastasios D. Papanastasiou Nicola Fusco Caterina Marchiò Nadeem R. Abu‐Rustum Rajmohan Murali Edi Brogi Hannah Y. Wen Larry Norton Robert A. Soslow Anne Vincent‐Salomon Jorge S. Reis‐Filho Britta Weigelt The genetic landscape of metaplastic breast cancers and uterine carcinosarcomas Molecular Oncology breast cancer carcinosarcoma homologous recombination DNA repair metaplastic uterine cancer whole‐exome sequencing |
title | The genetic landscape of metaplastic breast cancers and uterine carcinosarcomas |
title_full | The genetic landscape of metaplastic breast cancers and uterine carcinosarcomas |
title_fullStr | The genetic landscape of metaplastic breast cancers and uterine carcinosarcomas |
title_full_unstemmed | The genetic landscape of metaplastic breast cancers and uterine carcinosarcomas |
title_short | The genetic landscape of metaplastic breast cancers and uterine carcinosarcomas |
title_sort | genetic landscape of metaplastic breast cancers and uterine carcinosarcomas |
topic | breast cancer carcinosarcoma homologous recombination DNA repair metaplastic uterine cancer whole‐exome sequencing |
url | https://doi.org/10.1002/1878-0261.12813 |
work_keys_str_mv | AT leaamoukarzel thegeneticlandscapeofmetaplasticbreastcancersanduterinecarcinosarcomas AT lorenzoferrando thegeneticlandscapeofmetaplasticbreastcancersanduterinecarcinosarcomas AT arnauddacruzpaula thegeneticlandscapeofmetaplasticbreastcancersanduterinecarcinosarcomas AT davidnbrown thegeneticlandscapeofmetaplasticbreastcancersanduterinecarcinosarcomas AT felipecgeyer thegeneticlandscapeofmetaplasticbreastcancersanduterinecarcinosarcomas AT fresiapareja thegeneticlandscapeofmetaplasticbreastcancersanduterinecarcinosarcomas AT salvatorepiscuoglio thegeneticlandscapeofmetaplasticbreastcancersanduterinecarcinosarcomas AT anastasiosdpapanastasiou thegeneticlandscapeofmetaplasticbreastcancersanduterinecarcinosarcomas AT nicolafusco thegeneticlandscapeofmetaplasticbreastcancersanduterinecarcinosarcomas AT caterinamarchio thegeneticlandscapeofmetaplasticbreastcancersanduterinecarcinosarcomas AT nadeemraburustum thegeneticlandscapeofmetaplasticbreastcancersanduterinecarcinosarcomas AT rajmohanmurali thegeneticlandscapeofmetaplasticbreastcancersanduterinecarcinosarcomas AT edibrogi thegeneticlandscapeofmetaplasticbreastcancersanduterinecarcinosarcomas AT hannahywen thegeneticlandscapeofmetaplasticbreastcancersanduterinecarcinosarcomas AT larrynorton thegeneticlandscapeofmetaplasticbreastcancersanduterinecarcinosarcomas AT robertasoslow thegeneticlandscapeofmetaplasticbreastcancersanduterinecarcinosarcomas AT annevincentsalomon thegeneticlandscapeofmetaplasticbreastcancersanduterinecarcinosarcomas AT jorgesreisfilho thegeneticlandscapeofmetaplasticbreastcancersanduterinecarcinosarcomas AT brittaweigelt thegeneticlandscapeofmetaplasticbreastcancersanduterinecarcinosarcomas AT leaamoukarzel geneticlandscapeofmetaplasticbreastcancersanduterinecarcinosarcomas AT lorenzoferrando geneticlandscapeofmetaplasticbreastcancersanduterinecarcinosarcomas AT arnauddacruzpaula geneticlandscapeofmetaplasticbreastcancersanduterinecarcinosarcomas AT davidnbrown geneticlandscapeofmetaplasticbreastcancersanduterinecarcinosarcomas AT felipecgeyer geneticlandscapeofmetaplasticbreastcancersanduterinecarcinosarcomas AT fresiapareja geneticlandscapeofmetaplasticbreastcancersanduterinecarcinosarcomas AT salvatorepiscuoglio geneticlandscapeofmetaplasticbreastcancersanduterinecarcinosarcomas AT anastasiosdpapanastasiou geneticlandscapeofmetaplasticbreastcancersanduterinecarcinosarcomas AT nicolafusco geneticlandscapeofmetaplasticbreastcancersanduterinecarcinosarcomas AT caterinamarchio geneticlandscapeofmetaplasticbreastcancersanduterinecarcinosarcomas AT nadeemraburustum geneticlandscapeofmetaplasticbreastcancersanduterinecarcinosarcomas AT rajmohanmurali geneticlandscapeofmetaplasticbreastcancersanduterinecarcinosarcomas AT edibrogi geneticlandscapeofmetaplasticbreastcancersanduterinecarcinosarcomas AT hannahywen geneticlandscapeofmetaplasticbreastcancersanduterinecarcinosarcomas AT larrynorton geneticlandscapeofmetaplasticbreastcancersanduterinecarcinosarcomas AT robertasoslow geneticlandscapeofmetaplasticbreastcancersanduterinecarcinosarcomas AT annevincentsalomon geneticlandscapeofmetaplasticbreastcancersanduterinecarcinosarcomas AT jorgesreisfilho geneticlandscapeofmetaplasticbreastcancersanduterinecarcinosarcomas AT brittaweigelt geneticlandscapeofmetaplasticbreastcancersanduterinecarcinosarcomas |